115 related articles for article (PubMed ID: 27766561)
21. [Influence of neoadjuvant chemoradiotherapy on peritoneal wound healing after abdominoperineal resection].
Wang G; Yao X; Wu YJ; Tao KX; Gao JB
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Jun; 27(6):615-620. PubMed ID: 38901995
[No Abstract] [Full Text] [Related]
22. Impact of interval between neoadjuvant chemoradiotherapy and TME for locally advanced rectal cancer on pathologic response and oncologic outcome.
Wolthuis AM; Penninckx F; Haustermans K; De Hertogh G; Fieuws S; Van Cutsem E; D'Hoore A
Ann Surg Oncol; 2012 Sep; 19(9):2833-41. PubMed ID: 22451236
[TBL] [Abstract][Full Text] [Related]
23. Individualizing surgical treatment based on tumour response following neoadjuvant therapy in T4 primary rectal cancer.
Denost Q; Kontovounisios C; Rasheed S; Chevalier R; Brasio R; Capdepont M; Rullier E; Tekkis PP
Eur J Surg Oncol; 2017 Jan; 43(1):92-99. PubMed ID: 27717529
[TBL] [Abstract][Full Text] [Related]
24. Morbidity and mortality following abdominoperineal resection for low rectal adenocarcinoma.
Luna-Pérez P; Rodríguez-Ramírez S; Vega J; Sandoval E; Labastida S
Rev Invest Clin; 2001; 53(5):388-95. PubMed ID: 11795103
[TBL] [Abstract][Full Text] [Related]
25. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.
Beddy D; Hyland JM; Winter DC; Lim C; White A; Moriarty M; Armstrong J; Fennelly D; Gibbons D; Sheahan K
Ann Surg Oncol; 2008 Dec; 15(12):3471-7. PubMed ID: 18846402
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for surgical site infection after elective resection for rectal cancer. A multivariate analysis on 2131 patients.
Biondo S; Kreisler E; Fraccalvieri D; Basany EE; Codina-Cazador A; Ortiz H
Colorectal Dis; 2012 Mar; 14(3):e95-e102. PubMed ID: 21883813
[TBL] [Abstract][Full Text] [Related]
27. Utilization of interventional radiology in the postoperative management of patients after surgery for locally advanced and recurrent rectal cancer.
Llaguna OH; Calvo BF; Stitzenberg KB; Deal AM; Burke CT; Dixon RG; Stavas JM; Meyers MO
Am Surg; 2011 Aug; 77(8):1086-90. PubMed ID: 21944529
[TBL] [Abstract][Full Text] [Related]
28. Tumor regression grades: potential outcome predictor of locally advanced rectal adenocarcinoma after preoperative radiotherapy.
Peng YF; Yu WD; Pan HD; Wang L; Li M; Yao YF; Zhao J; Gu J
World J Gastroenterol; 2015 Feb; 21(6):1851-6. PubMed ID: 25684951
[TBL] [Abstract][Full Text] [Related]
29. Risk factors for surgical site infection following colorectal resection: a multi-institutional study.
Hennessey DB; Burke JP; Ni-Dhonochu T; Shields C; Winter DC; Mealy K
Int J Colorectal Dis; 2016 Feb; 31(2):267-71. PubMed ID: 26507963
[TBL] [Abstract][Full Text] [Related]
30. Can increasing the dose of radiation by HDR brachytherapy boost following pre operative chemoradiotherapy for advanced rectal cancer improve surgical outcomes?
Sun Myint A; Mukhopadhyay T; Ramani VS; Perkins K; Snee AJ; Jelley F; Wong H; Lee CD
Colorectal Dis; 2010 Aug; 12 Suppl 2():30-6. PubMed ID: 20618365
[TBL] [Abstract][Full Text] [Related]
31. Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC).
Vestermark LW; Jacobsen A; Qvortrup C; Hansen F; Bisgaard C; Baatrup G; Rasmussen P; Pfeiffer P
Acta Oncol; 2008; 47(3):428-33. PubMed ID: 18348002
[TBL] [Abstract][Full Text] [Related]
32. Multicenter surveillance study of surgical site infection and its risk factors in radical resection of colon or rectal carcinoma.
Du M; Liu B; Li M; Cao J; Liu D; Wang Z; Wang Q; Xiao P; Zhang X; Gao Y; Zeng H; Yang J; Xu X; Huang Y; Zhang Q; Zhang B; Chen W; Shi J; Fan S; Zhang F; Yang J; Yang H; Ding Z; Li H; Xiao S; Ran S; Zhai H; Wang F; Xing Y; Suo J; Liu Y
BMC Infect Dis; 2019 May; 19(1):411. PubMed ID: 31088389
[TBL] [Abstract][Full Text] [Related]
33. Oncologic results and prognostic predictors of patients with locally advanced rectal cancer showing ypN0 after radical surgery following neoadjuvant chemoradiotherapy.
Lee KH; Kim JC; Kim JY; Kim JS
Int J Colorectal Dis; 2015 Aug; 30(8):1041-50. PubMed ID: 26002751
[TBL] [Abstract][Full Text] [Related]
34. Long-term prognostic value of mesorectal grading after neoadjuvant chemoradiotherapy for rectal cancer.
Madbouly KM; Hussein AM; Abdelzaher E
Am J Surg; 2014 Sep; 208(3):332-41. PubMed ID: 24581995
[TBL] [Abstract][Full Text] [Related]
35. Deep-wound and organ-space infection after surgery for degenerative spine disease: an analysis from 2006 to 2012.
De la Garza-Ramos R; Abt NB; Kerezoudis P; McCutcheon BA; Bydon A; Gokaslan Z; Bydon M
Neurol Res; 2016 Feb; 38(2):117-23. PubMed ID: 27118607
[TBL] [Abstract][Full Text] [Related]
36. Pathologic response grade after long-course neoadjuvant chemoradiation does not influence morbidity in locally advanced mid-low rectal cancer resected by laparoscopy.
Landi F; Espín E; Rodrigues V; Vallribera F; Martinez A; Charpy C; Brunetti F; Azoulay D; de'Angelis N
Int J Colorectal Dis; 2017 Feb; 32(2):255-264. PubMed ID: 27757541
[TBL] [Abstract][Full Text] [Related]
37. The outcome and the frequency of pathological complete response after neoadjuvant radiotherapy in curative resections for advanced rectal cancer: a population-based study.
Wasmuth HH; Rekstad LC; Tranø G
Colorectal Dis; 2016 Jan; 18(1):67-72. PubMed ID: 26201935
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for anastomotic leakage after preoperative chemoradiation therapy and low anterior resection with total mesorectal excision for locally advanced rectal cancer.
Rodríguez-Ramírez SE; Uribe A; Ruiz-García EB; Labastida S; Luna-Pérez P
Rev Invest Clin; 2006; 58(3):204-10. PubMed ID: 16958295
[TBL] [Abstract][Full Text] [Related]
39. Could a wait and see policy be justified in T3/4 rectal cancers after chemo-radiotherapy?
Hughes R; Harrison M; Glynne-Jones R
Acta Oncol; 2010 Apr; 49(3):378-81. PubMed ID: 20151936
[TBL] [Abstract][Full Text] [Related]
40. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
